TRAIL
08 Jun 2021
Trial Summary
Tracking Residual Disease Using Circulating Tumour DNA In High-Risk Early Breast Cancer
Acronym:
TRAIL
ACTRN/NCT /ethics:
ACTRN12618001766202
Scientific title:
Tracking Residual Disease Using Circulating Tumour DNA In High-Risk Early Breast Cancer
Sponsor / Cooperative group:
National Breast Cancer Foundation
Trial & Patient Characteristics
| Cancer Type | Breast |
|---|---|
| Trial Type | Diagnosis |
| Phase | - |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | - |
| Anticipated Start Date | 2018-10-31 |
| Anticipated End Date | 2023-10-31 |
Participating Hospitals
| Hospital | Lyell McEwin Hospital |
|---|---|
| Clinical Trial Coordinator | Andy Phay |
| andy.phay@sa.gov.au | |
| Phone | 08 8282 0833 |
| Principal Investigator | Dr Hooi Hong |
| Recruitment Status | Recruiting |